151 related articles for article (PubMed ID: 10439796)
1. Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection.
Sabile A; Louha M; Bonte E; Poussin K; Vona G; Mejean A; Chretien Y; Bougas L; Lacour B; Capron F; Roseto A; Bréchot C; Paterlini-Bréchot P
Am J Clin Pathol; 1999 Aug; 112(2):171-8. PubMed ID: 10439796
[TBL] [Abstract][Full Text] [Related]
2. Detecting carcinoma cells in peripheral blood of patients with hepatocellular carcinoma by immunomagnetic beads and rt-PCR.
Guo J; Yao F; Lou Y; Xu C; Xiao B; Zhou W; Chen J; Hu Y; Liu Z
J Clin Gastroenterol; 2007 Sep; 41(8):783-8. PubMed ID: 17700428
[TBL] [Abstract][Full Text] [Related]
3. Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation.
Waguri N; Suda T; Nomoto M; Kawai H; Mita Y; Kuroiwa T; Igarashi M; Kobayashi M; Fukuhara Y; Aoyagi Y
Clin Cancer Res; 2003 Aug; 9(8):3004-11. PubMed ID: 12912949
[TBL] [Abstract][Full Text] [Related]
4. Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction.
Ghossein RA; Osman I; Bhattacharya S; Ferrara J; Fazzari M; Cordon-Cardo C; Scher HI
Diagn Mol Pathol; 1999 Jun; 8(2):59-65. PubMed ID: 10475379
[TBL] [Abstract][Full Text] [Related]
5. Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymeras chain reaction.
Guo J; Xiao B; Jin Z; Qin L; Chen J; Chen H; Zhang X; Liu Z
J Gastroenterol Hepatol; 2005 Aug; 20(8):1279-84. PubMed ID: 16048578
[TBL] [Abstract][Full Text] [Related]
6. Combined use of positive and negative immunomagnetic isolation followed by real-time RT-PCR for detection of the circulating tumor cells in patients with colorectal cancers.
Guo J; Xiao B; Zhang X; Jin Z; Chen J; Qin L; Mao X; Shen G; Chen H; Liu Z
J Mol Med (Berl); 2004 Nov; 82(11):768-74. PubMed ID: 15490093
[TBL] [Abstract][Full Text] [Related]
7. Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.
Ishikawa T; Kashiwagi H; Iwakami Y; Hirai M; Kawamura T; Aiyoshi Y; Yashiro T; Ami Y; Uchida K; Miwa M
Jpn J Clin Oncol; 1998 Dec; 28(12):723-8. PubMed ID: 9879288
[TBL] [Abstract][Full Text] [Related]
8. Real-Time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the taqman detection system.
Gelmini S; Tricarico C; Vona G; Livi L; Melina AD; Serni S; Cellai E; Magrini S; Villari D; Carini M; Serio M; Forti G; Pazzagli M; Orlando C
Clin Chem Lab Med; 2001 May; 39(5):385-91. PubMed ID: 11434386
[TBL] [Abstract][Full Text] [Related]
9. Identification of enhancer of zeste homolog 2 expression in peripheral circulating tumor cells in metastatic prostate cancer patients: a preliminary study.
Cho KS; Oh HY; Lee EJ; Hong SJ
Yonsei Med J; 2007 Dec; 48(6):1009-14. PubMed ID: 18159594
[TBL] [Abstract][Full Text] [Related]
10. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
11. Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies.
Bonmassar L; Fossile E; Scoppola A; Graziani G; Prete SP; Formica V; Cappelletti D; De Vecchis L; Cardillo A; Concolino F; D'Atri S; Balduzzi A; Torino F; Caporaso P; Greiner JW; Bonmassar E; Roselli M; Aquino A
Anticancer Res; 2010 Nov; 30(11):4721-30. PubMed ID: 21115931
[TBL] [Abstract][Full Text] [Related]
12. Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications.
Millon R; Jacqmin D; Muller D; Guillot J; Eber M; Abecassis J
Eur Urol; 1999 Oct; 36(4):278-85. PubMed ID: 10473985
[TBL] [Abstract][Full Text] [Related]
13. Detection and isolation of prostate cancer cells from peripheral blood and bone marrow.
Ellis WJ; Pfitzenmaier J; Colli J; Arfman E; Lange PH; Vessella RL
Urology; 2003 Feb; 61(2):277-81. PubMed ID: 12597930
[TBL] [Abstract][Full Text] [Related]
14. Immunobead RT-PCR versus regular RT-PCR amplification of CEA mRNA in peripheral blood.
Park S; Lee B; Kim I; Choi I; Hong K; Ryu Y; Rhim J; Shin J; Park SC; Chung H; Chung J
J Cancer Res Clin Oncol; 2001 Aug; 127(8):489-94. PubMed ID: 11501748
[TBL] [Abstract][Full Text] [Related]
15. The use of nested RT-PCR of prostate-specific membrane antigen in blood cells: implications for the detection of haematogenous neoplastic cells in patients with prostate adenocarcinoma.
Lucotte G; Mercier G; Burckel A
Mol Cell Probes; 1998 Dec; 12(6):421-5. PubMed ID: 9843660
[TBL] [Abstract][Full Text] [Related]
16. Development of a molecular multimarker assay for the analysis of circulating tumor cells in adenocarcinoma patients.
de Albuquerque A; Kubisch I; Ernst D; Breier G; Stamminger G; Fersis N; Stölzel U; Boese-Landgraf J; Eichler A; Kaul S
Clin Lab; 2012; 58(5-6):373-84. PubMed ID: 22783565
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical detection of circulating esophageal carcinoma cells by immunomagnetic separation.
Nakamura T; Yasumura T; Hayashi K; Eguchi R; Ide H; Takasaki K; Kasajima T
Anticancer Res; 2000; 20(6C):4739-44. PubMed ID: 11205210
[TBL] [Abstract][Full Text] [Related]
18. The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer.
Pfitzenmaier J; Ellis WJ; Hawley S; Arfman EW; Klein JR; Lange PH; Vessella RL
Urol Oncol; 2007; 25(3):214-20. PubMed ID: 17483018
[TBL] [Abstract][Full Text] [Related]
19. Correlation between CD8+ T cells specific for prostate-specific antigen and level of disease in patients with prostate cancer.
Elkord E; Rowbottom AW; Kynaston H; Williams PE
Clin Immunol; 2006 Jul; 120(1):91-8. PubMed ID: 16458609
[TBL] [Abstract][Full Text] [Related]
20. High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity.
Fizazi K; Morat L; Chauveinc L; Prapotnich D; De Crevoisier R; Escudier B; Cathelineau X; Rozet F; Vallancien G; Sabatier L; Soria JC
Ann Oncol; 2007 Mar; 18(3):518-21. PubMed ID: 17322541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]